It has been reported that SRSF1 was able to regulate EMT through disrupting the alternative splicing of key tumor associated genes, including Ron proto-oncogene [21], PRRC2C [22], and MKNK2 [23, 24], to modulate lung cancer progression. This evidence concerns the gene PRRC2C and lung cancer.